Fast Five Quiz: Chronic Spontaneous Urticaria

William D. James, MD

Disclosures

June 15, 2020

When treating patients with severe CSU, both the AAAI and EAACI/GA2LEN/ EDF/WAO guidelines encourage clinicians to first attempt to achieve symptom control by increasing the dose of the initially prescribed second-generation antihistamine, rather than prescribing multiple antihistamines. If symptom control is not achieved with higher-dose monotherapy, a leukotriene receptor agonist or low-dose corticosteroid therapy can be added.

Treating patients with several different antihistamines and prescribing a combination of antihistamines, antidepressant medications, and aspirin are not recommended treatments for patients with severe CSU.

Learn more about treating severe and refractory CSU.

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as:

processing....